Hims & Hers raises annual forecast revenue on strong subscriber growth
Original source: https://www.investing.com/news/stock-market-news/hims–hers-raises-annual-forecast-revenue-on-strong-subscriber-growth-4850181
Read More »Hims & Hers misses revenue estimates as strategy shift hits sales
Original source: https://www.investing.com/news/stock-market-news/hims–hers-misses-revenue-estimates-as-strategy-shift-hits-sales-4678803
Read More »Novo Nordisk and Hims & Hers agree to partner on obesity drugs
Original source: https://www.investing.com/news/stock-market-news/novo-nordisk-and-hims–hers-agree-to-partner-on-obesity-drugs-93CH-4548501
Read More »Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Original source: https://www.investing.com/news/stock-market-news/hims–hers-to-stop-offering-compounded-semaglutide-pill-after-fda-crackdown-4492374
Read More »Hims & Hers to sell Lilly’s weight-loss drug on its telehealth platform (April 1)
Original source: https://www.investing.com/news/stock-market-news/hims–hers-to-sell-lillys-zepbound-on-its-telehealth-platform-3961091
Read More »